Patients with atrial fibrillation often take multiple medications. In the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF) study population, we examined patient characteristics and compared adjusted outcomes between rivaroxaban and warfarin according to number of concomitant baseline medications and the presence of combined cytochrome P450 3A4 and P-glycoprotein inhibitors. Among ROCKET AF patients (nonvalvular atrial fibrillation with moderate to high risk of stroke), polypharmacy was not infrequent. Two thirds of the patients were on ≥5 medications. Increasing medication use was associated with higher risk of bleeding but not stroke risk. There was no evidence of differential outcomes in those treated with rivaroxaban versus warfarin according to the number of concomitant medications, except for lower risk of major bleeding in those treated with rivaroxaban and <5 medications. There was no evidence of heterogeneity of treatment outcomes according to the use of combined cytochrome P450 3A4 and P-glycoprotein inhibitors unless patients were taking ≥2 combined inhibitors. In summary, rivaroxaban was tolerated across complex patients on multiple medications. See p 352.
Novel Biomarker of Oxidative Stress Is Associated With Risk of Death in Patients With Coronary Artery Disease
Although oxidative stress is a critically important process in atherosclerosis, observational evidence and clinical trials of free radical scavengers have proven uniformly disappointing. This has promoted the concept that clinically important oxidative stress may be mediated by nonfree radical species. Proteins with reactive aminothiols are susceptible to oxidation, and quantification of these reduced and oxidized (redox) residues offers an alternative means of quantifying in vivo oxidative stress and oxidant burden. Having developed means to reliably collect and quantify these markers in plasma, we have previously shown associations with multiple risk factors for cardiovascular disease as well as with subclinical markers such as arterial stiffness and intima media thickness. However, whether these markers are clinically relevant has remained unknown. In this study, we now present long-term outcome data demonstrating association between these redox markers and adverse cardiovascular outcomes and mortality. These findings are important as they support the use of these aminothiols as novel and reliable biomarkers of oxidative stress. Importantly, given that oxidation of these aminothiols leads to altered cellular signaling, these findings may offer new opportunities for therapeutic interventions for reducing the adverse clinical impact of oxidative stress in vivo. See p 361.
Sugar-Sweetened Beverage Consumption Is Associated With Change of Visceral Adipose Tissue Over 6 Years of Follow-Up
Excess sugar-sweetened beverage consumption has been linked to increased risk of cardiovascular disease and type 2 diabetes mellitus. In this study, we conducted a prospective observational study that examined the association between habitual intake of sugar-sweetened beverages and change in visceral adipose tissue. We examined data collected from 1,003 middleage adults, mean age 45.3 years and 45% women, who attended the Framingham Heart Study's Third Generation Cohort. These participants were examined at baseline and approximately 6 years later. This study demonstrated a dose-response relationship between sugar-sweetened beverage consumption and change in visceral adipose tissue. Higher sugar-sweetened beverage consumption was associated with higher fat accumulation and adverse change of quality in visceral adipose tissue. Our findings provide evidence for further studies regarding underlying mechanisms leading sugar-sweetened beverage intake to cardiometabolic diseases. Our observations highlight the importance of the current dietary recommendations to limit sugar-sweetened beverage consumption. See p 370.
Traffic-Related Air Pollution, Blood Pressure, and Adaptive Response of Mitochondrial Abundance
Traffic-related pollution (black carbon [BC] ) is a pervasive environmental threat, particularly for older individuals, who are especially susceptible to pollution-triggered cardiovascular morbidity and mortality. Systemic oxidative stress is a key mechanism linking BC pollution and cardiovascular events, and the role of mitochondria abundance in compensating for cellular-redox imbalance under oxidative stress has been increasingly appreciated. However, the response of mitochondria in the peripheral blood on ambient BC exposure remains unknown. We used the Normative Aging Study to address a mechanistic question about cardiovascular effects of air pollution: how does short-term to moderate-term ambient BC alter blood mitochondrial abundance, and how might this alteration impact BC-elicited cardiovascular effects? Our results indicated that, in older adults, levels of short-term to moderate-term ambient BC were associated with increased blood pressure and blood mitochondrial abundance. In addition, individuals with lower blood mitochondrial abundance were estimated to exhibit 1.95-fold larger effect of BC with systolic blood pressure, suggesting that increased blood mitochondrial abundance buffered the effect of ambient BC on blood pressure. The impact of our study is in the investigation of the compensatory increase in blood mitochondrial abundance as an adaptive response to reduce the cardiovascular effects of ambient BC. The present study provides insights into the physiological effects of traffic-related pollution and may aid targeted risk-reduction and novel pharmaceutical interventions. Because of the central role of oxidative stress in the pathogenesis of cardiovascular diseases, the study results may 
Isoproterenol Promotes Rapid Ryanodine Receptor Movement to Bridging Integrator 1 (BIN1)-Organized Dyads
Heart failure is the fastest-growing cardiovascular disorder, affecting >6 million Americans with 600 000 new cases per year, and 50 000 to 100 000 individuals are in end-stage disease refractory to medical therapy. Acquired heart failure, usually resulting from ischemic cardiomyopathy, is the most common form of heart failure in the United States. For ischemic cardiomyopathy, as with other acquired dilated cardiomyopathies, it is well understood that impaired sarcomeric dyad function leads to diminished calcium transients, which decreases contractility, contributing to the progression of heart failure. The dyad is coupling between t-tubule L-type calcium channels with nearby sarcoplasmic membrane ryanodine receptors. The mechanisms by which dyad function is negatively affected in heart failure remain incompletely understood. Here, we report that dynamic movement of ryanodine receptors into dyads for L-type calcium channel-ryanodine receptors complex formation is under the control of membrane microdomains organized by a particular cytoskeleton and membrane scaffolding protein bridging integrator 1 (BIN1), which helps to maintain excitation-contraction coupling during adrenergic stress. In acquired human heart failure, BIN1 is reduced, and orphaned phosphorylated ryanodine receptors accumulate outside of dyads, lessening contractility and increasing arrhythmogenesis. The results suggest that interventions that preserve BIN1-organized t-tubule microdomains could be of therapeutic benefit to improve cardiac function and to lessen arrhythmia in millions of patients with failing hearts. See p 388.
Establishing International Blood Pressure References Among Nonoverweight Children and Adolescents Aged 6 to 17 Years
Elevated blood pressure (BP) in children and adolescents is both a clinical and a public health concern worldwide.
The screening and treatment of hypertension require that elevated BP is well defined in children and adolescents. In the absence of solid cohort data to define the risk associated with BP in children, the distribution of BP is usually used to define BP categories in youths. US BP references from the Fourth Report are widely used worldwide, but there has been no attempt to define BP references based on BP data from multiple countries. We therefore developed international BP percentiles by sex, age, and height among 52 636 nonoverweight children and adolescents aged 6 to 19 years by using nationally representative data sets from 7 countries (China, India Iran, Korea, Poland, Tunisia, and the United States). This new international BP reference based on the distribution of BP from multiple countries may have advantages for the identification of children and adolescents who have elevated BP in different populations and for the comparison of the prevalence of elevated BP between countries. See p 398.
Targeting NCK-Mediated Endothelial Cell Front-Rear Polarity Inhibits Neovascularization
Sprouting angiogenesis drives neovascularization in pathologies including age-related macular degeneration, wound healing, and cancer. Endothelial cells forming the sprout switch from a lumenized phenotype with apicobasal polarity to a nonlumenized tip cell with front-rear polarity. Here, we show that the Nck1 and 2 adaptor proteins are required for endothelial cell front-rear polarity and sprouting angiogenesis. Mice carrying inducible, endothelial-specific Nck1/2 deletions fail to develop front-rear polarized vessel sprouts and exhibit severe sprouting angiogenesis defects. Mechanistically, NCK1 and 2 promote polarity by activating Cdc42 and Pak2 downstream of VEGF-A and Slit2 signaling pathways. NCK1/2 coordinates the functional interaction between VEGF-A and Slit2 signaling required for front-rear polarity and sprouting angiogenesis. Targeting this interaction inhibits pathological ocular angiogenesis and wound healing, allowing for the generation of novel therapeutics to prevent neovascularization. See p 409.
